Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0000874015-25-000228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-09 | 2025-09-05 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $62.00 | -250 | 31.9K | -0.8% | -$15.5K |
| D | 2025-09-09 | 2025-09-05 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $31.80 | +250 | 32.2K | +0.8% | +$7,950 |
| D | 2025-09-09 | 2025-09-05 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | -250 | 53.6K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 250 | $62.00 | 31,926 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025. |
| 2 | Common | Common Stock | 2025-09-05 | M | A | 250 | $31.80 | 32,176 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-09-05 | M | D | 250 | $0.00 | 53,650 | D | $31.80 · 2023-01-31 to 2032-01-30 | 250 Common Stock |